Status:

COMPLETED

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Lead Sponsor:

Case Comprehensive Cancer Center

Conditions:

Solid Tumor

Cancer

Eligibility:

All Genders

18+ years

Phase:

EARLY_PHASE1

Brief Summary

This research study examines the safety and feasibility of aspirin with or without Simvastatin in solid tumor patients at risk for VTE (Venous Thromboembolism - or blood clots - in the arms, lets, lun...

Detailed Description

Objectives Primary: To determine efficacy of aspirin with and without simvastatin in solid tumor patients at high- or intermediate-risk for VTE, in reducing markers of platelet activation, levels of ...

Eligibility Criteria

Inclusion

  • Histologic diagnosis of malignancy of a solid organ or lymphoma
  • Planned to initiate a new systemic chemotherapy regimen (including patients starting on first chemotherapy or patients previously treated but starting on a new regimen)
  • VTE Risk Score ≥1
  • Written, informed consent.

Exclusion

  • Hematologic malignancies including acute and chronic leukemias, myelodysplastic syndromes, lymphoma and myeloma
  • Primary brain tumors
  • Active bleeding or high risk of bleeding in the opinion of the investigator
  • Hepatic dysfunction (elevated transaminases or bilirubin \> 3 times normal)
  • Planned stem cell transplant
  • Life expectancy \< 6 months
  • Acute or chronic renal insufficiency with creatinine clearance \< 30 mL/min
  • Pregnancy
  • Known allergy to or prior intolerance of aspirin and/or simvastatin.
  • Ongoing anticoagulant, statin and/or anti-platelet therapy.

Key Trial Info

Start Date :

December 30 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2018

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT02285738

Start Date

December 30 2014

End Date

October 1 2018

Last Update

May 8 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center

Cleveland, Ohio, United States, 44195